Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape

Target Audience
This educational activity is directed toward hematologists and hematologist-oncologists, as well as pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with beta-thalassemia.

Program Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of β-thalassemia, with a forward-looking perspective on how new and novel agents might impact clinical practice. An overview of β-thalassemia, as well as current and emerging treatment strategies, will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Understand the pathophysiology of iron overload in β-thalassemia
Identify patients with iron overload in patients with β-thalassemia
Apply current guidelines for the management of β-thalassemia
Assess clinical trial data for safety and efficacy of new and emerging therapies for β-thalassemia